Debt-to-equity of Niagen Bioscience, Inc. from 27 Sep 2014 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Niagen Bioscience, Inc. quarterly Debt-to-equity in % history and change rate from 27 Sep 2014 to 31 Dec 2025.
  • Niagen Bioscience, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 41%, a 37% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Niagen Bioscience, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 41% -25% -37% 31 Dec 2025
Q3 2025 44% -36% -45% 30 Sep 2025
Q2 2025 49% -39% -44% 30 Jun 2025
Q1 2025 56% -37% -39% 31 Mar 2025
Q4 2024 66% -28% -30% 31 Dec 2024
Q3 2024 79% -14% -15% 30 Sep 2024
Q2 2024 88% -9.5% -9.8% 30 Jun 2024
Q1 2024 93% -10% -10% 31 Mar 2024
Q4 2023 94% -13% -12% 31 Dec 2023
Q3 2023 93% -11% -11% 30 Sep 2023
Q2 2023 97% +5.7% +6.3% 30 Jun 2023
Q1 2023 103% +28% +37% 31 Mar 2023
Q4 2022 107% +42% +64% 31 Dec 2022
Q3 2022 104% +35% +50% 30 Sep 2022
Q2 2022 91% +19% +26% 30 Jun 2022
Q1 2022 75% -9% -11% 31 Mar 2022
Q4 2021 65% -42% -39% 31 Dec 2021
Q3 2021 70% -29% -30% 30 Sep 2021
Q2 2021 73% -15% -17% 30 Jun 2021
Q1 2021 84% -22% -21% 31 Mar 2021
Q4 2020 107% +4.2% +4.1% 31 Dec 2020
Q3 2020 99% +8.9% +9.9% 30 Sep 2020
Q2 2020 88% +6.1% +7.5% 30 Jun 2020
Q1 2020 106% +56% +112% 31 Mar 2020
Q4 2019 103% +68% +197% 31 Dec 2019
Q3 2019 90% +64% +249% 30 Sep 2019
Q2 2019 82% +59% +262% 30 Jun 2019
Q1 2019 50% +28% +130% 31 Mar 2019
Q4 2018 35% +5.4% +18% 31 Dec 2018
Q3 2018 26% -21% -45% 30 Sep 2018
Q2 2018 23% -40% -64% 30 Jun 2018
Q1 2018 22% -55% -72% 31 Mar 2018
Q4 2017 29% -50% -63% 30 Dec 2017
Q3 2017 47% -53% -53% 30 Sep 2017
Q2 2017 62% -77% -55% 01 Jul 2017
Q1 2017 77% -147% -66% 01 Apr 2017
Q4 2016 79% -164% -68% 31 Dec 2016
Q3 2016 99% -126% -56% 01 Oct 2016
Q2 2016 139% -43% -24% 02 Jul 2016
Q1 2016 224% +81% +57% 02 Apr 2016
Q4 2015 243% +130% +115% 02 Jan 2016
Q3 2015 225% +144% +176% 03 Oct 2015
Q2 2015 182% 04 Jul 2015
Q1 2015 143% 04 Apr 2015
Q4 2014 113% 03 Jan 2015
Q3 2014 82% 27 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.